534733 (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 35 equity scrips effective May 18, 2026, with bands revised to 1%, 2%, 5%, or 10% under surveillance department … | |||||||||||||||
BSE revises price bands for 35 equity scrips effective May 18, 2026, with bands revised to 1%, 2%, 5%, or 10% under surveillance department action.
| |||||||||||||||
BSE has revised price bands for 21 equity scrips under surveillance, effective May 4, 2026. Bands range from 2% to 20% depending on the … | |||||||||||||||
BSE has revised price bands for 21 equity scrips under surveillance, effective May 4, 2026. Bands range from 2% to 20% depending on the scrip.
| |||||||||||||||
BSE revises price bands for 20 scrips including Aerpace Industries, Bandaram Pharma, HRS Aluglaze and others, effective from January 2, … | |||||||||||||||
BSE revises price bands for 20 scrips including Aerpace Industries, Bandaram Pharma, HRS Aluglaze and others, effective from January 2, 2026.
| |||||||||||||||